Fatty liver disease or hepatic steatosis, marked by increased accumulation of triglycerides in the liver, is brought on by chronic over-nutrition and increases the risk for secondary conditions such as insulin resistance. Mice with a targeted mutation in the enzyme stearoyl-CoA desaturase 1 (SCD1), which catalyzes the conversion of stearic acid into oleic acid, are lean and protected from diet-induced obesity as well as insulin resistance. This leads us to hypothesize that oleate, the monounsaturated fatty acid product of SCD1, plays a direct role in the development of diet-induced hepatic steatosis. 8-week old male wild-type (WT) and SCD1−/ − mice were fed 20% high-fat diets containing either tristearin or triolein for 7 days. Triolein feeding resulted in significantly greater body weight and adipose tissue gains, as well as greater hepatic triglyceride and cholesteryl ester accumulation in WT and SCD1−/ − mice. Expression of lipogenic genes and the transcription factors SREBP-1c and PGC-1β, as measured by real-time PCR, were increased by triolein feeding in both WT and SCD1−/ − animals. Conversely, activity of the AMP-activated protein kinase (AMPK)- α1 was significantly higher in livers of SCD1−/ − mice after tristearin feeding but was unchanged in WT animals. Taken together, these results suggest that triolein feeding increases lipogenesis in WT and SCD1−/ − animals and downregulates lipid oxidation in SCD1−/ − animals. These data help clarify the roles of specific fatty acids in the modulation of hepatic lipid metabolism. This work has been supported by NIH Grant NIDDK-R0162388 (JMN) and American Heart Association Predoctoral fellowship 0415001Z (HS).
Read full abstract